Clinical Trial Update: A Study to Evaluate Efficacy and Safety of ASP015K in Patients With Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate (MTX) Treatment [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the efficacy and safety of ASP015K in rheumatoid arthritis patients with inadequate response to methotrexate has completed. Results wer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ASP015K

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2020-08-03